235 related articles for article (PubMed ID: 34876842)
1. Exploring Prognosis-Associated Biomarkers of Estrogen-Independent Uterine Corpus Endometrial Carcinoma by Bioinformatics Analysis.
Ye Y; Li H; Bian J; Wang L; Wang Y; Huang H
Int J Gen Med; 2021; 14():9067-9081. PubMed ID: 34876842
[TBL] [Abstract][Full Text] [Related]
2. Identification of Hub Genes Correlated With Poor Prognosis for Patients With Uterine Corpus Endometrial Carcinoma by Integrated Bioinformatics Analysis and Experimental Validation.
Yuan Y; Chen Z; Cai X; He S; Li D; Zhao W
Front Oncol; 2021; 11():766947. PubMed ID: 34868993
[TBL] [Abstract][Full Text] [Related]
3. Construction of dysregulated long non-coding RNA-associated competing endogenous RNA network in uterine corpus endometrial carcinoma.
Li N; Mi P; Hu Y
Transl Cancer Res; 2020 Feb; 9(2):669-682. PubMed ID: 35117412
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive bioinformatic analyses of lncRNA-mediated ceRNA network for uterine corpus endometrial carcinoma.
Cai Y; Cui J; Wang Z; Wu H
Transl Cancer Res; 2022 Jul; 11(7):1994-2012. PubMed ID: 35966302
[TBL] [Abstract][Full Text] [Related]
5. Identification of lncRNAs associated with uterine corpus endometrial cancer prognosis based on the competing endogenous RNA network.
Wang L; Su X; Wang L; Luo J; Xiong Z; Leung GHD; Zhou J; Yang G; Zhai L; Zhang X; Liu Q; Lu G; Wang Y
Int J Med Sci; 2023; 20(12):1600-1615. PubMed ID: 37859697
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel key genes associated with uterine corpus endometrial carcinoma progression and prognosis.
Li H; Zhou Q; Wu Z; Lu X
Ann Transl Med; 2023 Jan; 11(2):100. PubMed ID: 36819577
[TBL] [Abstract][Full Text] [Related]
7. [Dysregulation of MAD2L1/CAMK2A/PTTG1 Gene Cluster Maintains the Stemness Characteristics of Uterine Corpus Endometrial Carcinoma].
Zheng J; Zhang YW; Pan ZF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Oct; 43(5):685-695. PubMed ID: 34728029
[TBL] [Abstract][Full Text] [Related]
8. Construction of a Competitive Endogenous RNA Network in Uterine Corpus Endometrial Carcinoma.
Ouyang D; Li R; Li Y; Zhu X
Med Sci Monit; 2019 Oct; 25():7998-8010. PubMed ID: 31650984
[TBL] [Abstract][Full Text] [Related]
9. Identification of a five-gene signature for predicting the progression and prognosis of stage I endometrial carcinoma.
Bian J; Xu Y; Wu F; Pan Q; Liu Y
Oncol Lett; 2020 Sep; 20(3):2396-2410. PubMed ID: 32782557
[TBL] [Abstract][Full Text] [Related]
10. Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma.
Chen Y
Front Genet; 2022; 13():912037. PubMed ID: 35937995
[No Abstract] [Full Text] [Related]
11. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
12. A 7-lncRNA signature predict prognosis of Uterine corpus endometrial carcinoma.
Ouyang D; Li R; Li Y; Zhu X
J Cell Biochem; 2019 Oct; 120(10):18465-18477. PubMed ID: 31168849
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of oxeiptosis-associated lncRNAs and prognosis-related signature genes to predict the immune status in uterine corpus endometrial carcinoma.
Niu L; Wu Z
Aging (Albany NY); 2023 May; 15(10):4236-4252. PubMed ID: 37211398
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics analysis of RNA sequencing data reveals multiple key genes in uterine corpus endometrial carcinoma.
Shen L; Liu M; Liu W; Cui J; Li C
Oncol Lett; 2018 Jan; 15(1):205-212. PubMed ID: 29387216
[TBL] [Abstract][Full Text] [Related]
15. LHX1 as a potential biomarker regulates EMT induction and cellular behaviors in uterine corpus endometrial carcinoma.
Tian Y; Wen F; Wang S; Lv N
Clinics (Sao Paulo); 2022; 77():100103. PubMed ID: 36116266
[TBL] [Abstract][Full Text] [Related]
16. The Expression of Pyroptosis-Related Gene May Influence the Occurrence, Development, and Prognosis of Uterine Corpus Endometrial Carcinoma.
Huang X; Li Y; Li J; Yang X; Xiao J; Xu F
Front Oncol; 2022; 12():885114. PubMed ID: 35574367
[TBL] [Abstract][Full Text] [Related]
17. KDM4B, a potential prognostic biomarker revealed by large-scale public databases and clinical samples in uterine corpus endometrial carcinoma.
Zhang M; Liu Y; Hou S; Wang Y; Wang C; Yin Y; Chen X
Mol Omics; 2022 Jul; 18(6):506-519. PubMed ID: 35485290
[TBL] [Abstract][Full Text] [Related]
18. Identification of the prognostic value of a 2-gene signature of the WNT gene family in UCEC using bioinformatics and real-world data.
Hu Y; Zheng M; Zhang D; Gou R; Liu O; Wang S; Lin B
Cancer Cell Int; 2021 Sep; 21(1):516. PubMed ID: 34565373
[TBL] [Abstract][Full Text] [Related]
19. The Analysis of ceRNA Networks and Tumor Microenvironment in Endometrial Cancer.
Huang J; Yang X; Xu S; Li P
J Cancer; 2024; 15(8):2147-2159. PubMed ID: 38495486
[No Abstract] [Full Text] [Related]
20. Immune and Metabolic Dysregulated Coding and Non-coding RNAs Reveal Survival Association in Uterine Corpus Endometrial Carcinoma.
Liu D; Qiu M
Front Genet; 2021; 12():673192. PubMed ID: 34249094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
